Review Article
Pathological Scenario with the Mannose-Binding Lectin in Patients with IgA Nephropathy
Table 1
Serum levels of complement components in patients with IgA nephropathy [
7].
| | | CH50 | C1q | C4 | C3 | C5 | B | P | MBL | (U/mL) | (mg/dL) | (mg/dL) | (mg/dL) | (%) | (%) | (mg/mL) | (mg/mL) |
| IgA nephropathy | 50 | 44.0 ± 8.1* | 13.4 ± 2.8 | 28 ± 11* | 101 ± 26 | 122 ± 28 | 114 ± 32* | 32.6 ± 27.0* | 1.8 ± 1.8 | Healthy controls | 50 | 33.5 ± 5.4 | 12.6 ± 1.7 | 21 ± 5 | 106 ± 17 | 112 ± 17 | 95 ± 18 | 21.0 ± 24.0 | 2.1 ± 1.8 |
|
|
% expresses a percentage of pooled normal human serum, *: IgA nephropathy versus healthy controls.
|